Stocks
Health Care
vtgn
VistaGen Therapeutics
NASDAQ: VTGN
-0.00 (-0.67%)
0.6059
USD
At close at Mar 04, 21:40 UTC
Income Statement
Revenue
698.00K
Gross Profit
698.00K
Operating Income
-52.84M
Pretax Income
-61.55M
Net Income
-47.30M
EBITDA
-46.68M
EBIT
-47.30M
Earnings Per Share
-1.48
Balance Sheet
Cash & Cash Equivalents
95.26M
Total Debt
1.90M
Net Cash
-
Net Cash Per Share
-
Equity (Book Value)
98.30M
Book Value Per Share
3.61
Working Capital
-
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.